Patrick McKiernan - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Patrick McKiernan's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Patrick McKiernan
Verified
Editor, Metal and Agriculture Markets, Bloomberg News
South Orange
Beats
AI, Business Domains, Blockchain , Domain Name Investments, Entrepreneurship , Information Technology
cats, socks, werewolves
Content
O12 Hepatic parameters, growth, and sleep with responders and nonresponders to odevixibat treatment: pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis | Frontline Gastroenterology
By Patrick McKiernan Verified, Ekkehard Sturm, Binita M. Kamath, Richard Thompson| Frontline Gastroenterology Verified AbstractIntroduction/Background Progressive familial intrahepatic cholestasis (PFIC) is a group of inherited paediatric cholestatic liver diseases. In the phase 3 PEDFIC 1 and PEDFIC 2 studies, odevixibat, an ileal bile acid transporter inhibitor, reduced serum bile acids (sBAs) and improved pruritus in patients with PFIC.
By Patrick McKiernan Verified| Bloomberg News Verified LISTEN TO ARTICLE 1:52 Boxes of assorted chocolates sit on display for sale at the Hershey Co. Chocolate World store in Hershey, Pennsylvania, U.S., on Friday, July 13, 2018. Hershey Co. is scheduled to release earnings figures on July 26. Photographer: Angus Mordant/Bloomberg Photographer: Angus Mordant/Bloomberg Cocoa futures capped the biggest weekly gain in 19 years amid jitters on West African trade and supply, pacing a rally in soft commodities.
O12 Hepatic parameters, growth, and sleep with responders and nonresponders to odevixibat treatment: pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis | Frontline Gastroenterology
By Patrick McKiernan Verified, Ekkehard Sturm, Binita M. Kamath, Richard Thompson| Frontline Gastroenterology Verified AbstractIntroduction/Background Progressive familial intrahepatic cholestasis (PFIC) is a group of inherited paediatric cholestatic liver diseases. In the phase 3 PEDFIC 1 and PEDFIC 2 studies, odevixibat, an ileal bile acid transporter inhibitor, reduced serum bile acids (sBAs) and improved pruritus in patients with PFIC.
Company Info
Bloomberg News
Bloomberg L.P. is a global financial data, software, and media company founded in 1981 by Michael Bloomberg and his partners. Originally named Innovative Market Systems, it rebranded to Bloomberg L.P. in 1986. The company is renowned for the Bloomberg Terminal, a proprietary platform that provides real-time financial data, analytics, and trading tools to over 350,000 subscribers worldwide. Bloomberg operates in three main areas: financial technology, news/media, and data analytics. Its flagship product, the Bloomberg Terminal, offers market data, news, and communication tools for financial professionals. Bloomberg News, with over 120 bureaus globally, covers financial markets, politics, and technology across various platforms, including digital, television, and print. The company also provides specialized data and analytics services, including legal and regulatory information, through its acquisitions. Bloomberg L.P. is privately held, with an estimated revenue of $12.5 billion in 2023, primarily from terminal subscriptions.
'+1 212-318-2000
Founded: 1981